Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach

Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Jama. 1990, 264 (19): 2511-2518. 10.1001/jama.264.19.2511.

Hasin DS, Glick H: Depressive symptoms and DSM-III-R alcohol dependence: general population results. Addiction. 1993, 88 (10): 1431-1436. 10.1111/j.1360-0443.1993.tb02030.x.

Lynskey MT: The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug Alcohol Depend. 1998, 52 (3): 201-209. 10.1016/S0376-8716(98)00095-7.

Wang J, El-Guebaly N: Sociodemographic factors associated with comorbid major depressive episodes and alcohol dependence in the general population. Can J Psychiatry. 2004, 49 (1): 37-44.

Goodwin FKJ: Manic-Depressive Illness. 2007, New York, NY , Oxford University Press, Second

Dick DM, Bierut LJ: The genetics of alcohol dependence. Curr Psychiatry Rep. 2006, 8 (2): 151-157. 10.1007/s11920-006-0015-1.

Dohrenwend BP, Levav I, Shrout PE, Schwartz S, Naveh G, Link BG, Skodol AE, Stueve A: Socioeconomic status and psychiatric disorders: the causation-selection issue. Science. 1992, 255 (5047): 946-952. 10.1126/science.1546291.

Kendler KS, Davis CG, Kessler RC: The familial aggregation of common psychiatric and substance use disorders in the national comorbidity survey: a family history study. Br J Psychiatry. 1997, 170: 541-548. 10.1192/bjp.170.6.541.

Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ: Alcoholism and major depression in women. A twin study of the causes of comorbidity. Arch Gen Psychiatry. 1993, 50 (9): 690-698.

Prescott CA, Aggen SH, Kendler KS: Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. Arch Gen Psychiatry. 2000, 57 (8): 803-811. 10.1001/archpsyc.57.8.803.

Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2007, 35 (Database issue): D26-31. 10.1093/nar/gkl993.

Carlson CS, Eberle MA, Kruglyak L, Nickerson DA: Mapping complex disease loci in whole-genome association studies. Nature. 2004, 429 (6990): 446-452. 10.1038/nature02623.

Clark AG, Boerwinkle E, Hixson J, Sing CF: Determinants of the success of whole-genome association testing. Genome Res. 2005, 15 (11): 1463-1467. 10.1101/gr.4244005.

Lawrence RW, Evans DM, Cardon LR: Prospects and pitfalls in whole genome association studies. Philos Trans R Soc Lond B Biol Sci. 2005, 360 (1460): 1589-1595. 10.1098/rstb.2005.1689.

Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Edgar R, Federhen S, Feolo M, Geer LY, Helmberg W, Kapustin Y, Khovayko O, Landsman D, Lipman DJ, Madden TL, Maglott DR, Miller V, Ostell J, Pruitt KD, Schuler GD, Shumway M, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov RL, Tatusova TA, Wagner L, Yaschenko E: Database resources of the national center for biotechnology information. Nucleic Acids Res. 2007

The Medical subject headings (MeSH) database [http://www.nlm.nih.gov/mesh/meshhome.html].

The database for annotation, visualization and integrated discovery (DAVID) [http://david.abcc.ncifcrf.gov/home.jsp].

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25 (1): 25-29. 10.1038/75556.

Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4 (5): P3-10.1186/gb-2003-4-5-p3.

Keller BJ, McEachin RC, Watanabe RM, McInnis MG: Identifying hypothetical genetic influences on complex disease phenotypes: San Francisco, California.2008, American Medical Informatics Association,

Hartman JL, Garvik B, Hartwell L: Principles for the buffering of genetic variation. Science. 2001, 291 (5506): 1001-1004. 10.1126/science.291.5506.1001.

Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T: Pathway mapping tools for analysis of high content data. Methods Mol Biol. 2007, 356: 319-350.

Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, Sorokina S, Ryabov A, Serebryiskaya T, Melnikov A, Metz J, Nikolskaya T: Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica. 2006, 36 (10-11): 877-901. 10.1080/00498250600861660.

Acheampong E, Mukhtar M, Parveen Z, Ngoubilly N, Ahmad N, Patel C, Pomerantz RJ: Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology. 2002, 304 (2): 222-234. 10.1006/viro.2002.1666.

Kahl KG, Kruse N, Faller H, Weiss H, Rieckmann P: Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology. 2002, 27 (6): 671-681. 10.1016/S0306-4530(01)00068-3.

Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE: The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2005, 14 (5): 1198-1203. 10.1158/1055-9965.EPI-04-0840.

Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day IN, Ebrahim S: The thermolabile variant of MTHFR is associated with depression in the British women's heart and health Study and a meta-analysis. Mol Psychiatry. 2006, 11 (4): 352-360. 10.1038/sj.mp.4001790.

Song K, Zhao XJ, Marrero L, Oliver P, Nelson S, Kolls JK: Alcohol reversibly disrupts TNF-alpha/TACE interactions in the cell membrane. Respir Res. 2005, 6: 123-10.1186/1465-9921-6-123.

Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, Mahendran R: Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet. 2004, 14 (4): 227-231. 10.1097/00041444-200412000-00012.

Chen PC, DuBois GC, Chen MJ: Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors. J Biol Chem. 1995, 270 (6): 2874-2878. 10.1074/jbc.270.6.2512.

Natoli G, Costanzo A, Guido F, Moretti F, Levrero M: Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem Pharmacol. 1998, 56 (8): 915-920. 10.1016/S0006-2952(98)00154-3.

Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A, Scheurich P, Mauri D, Wajant H: Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. J Biol Chem. 2004, 279 (1): 677-685. 10.1074/jbc.M310969200.

Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB: Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Arch Biochem Biophys. 1998, 352 (1): 59-70. 10.1006/abbi.1998.0576.

Liu H, Sidiropoulos P, Song G, Pagliari LJ, Birrer MJ, Stein B, Anrather J, Pope RM: TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. J Immunol. 2000, 164 (8): 4277-4285.

Moat SJ, Ashfield-Watt PA, Powers HJ, Newcombe RG, McDowell IF: Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clin Chem. 2003, 49 (2): 295-302. 10.1373/49.2.295.

Pickell L, Tran P, Leclerc D, Hiscott J, Rozen R: Regulatory studies of murine methylenetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity. Biochim Biophys Acta. 2005, 1731 (2): 104-114.

Mason JB, Choi SW: Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol. 2005, 35 (3): 235-241. 10.1016/j.alcohol.2005.03.012.

Mischoulon D, Raab MF: The role of folate in depression and dementia. J Clin Psychiatry. 2007, 68 Suppl 10: 28-33.

Coppen A, Abou-Saleh MT: Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry. 1982, 141: 87-89. 10.1192/bjp.141.1.87.

Coppen A, Swade C, Jones SA, Armstrong RA, Blair JA, Leeming RJ: Depression and tetrahydrobiopterin: the folate connection. J Affect Disord. 1989, 16 (2-3): 103-107. 10.1016/0165-0327(89)90062-1.

Folstein M, Liu T, Peter I, Buell J, Arsenault L, Scott T, Qiu WW: The homocysteine hypothesis of depression. Am J Psychiatry. 2007, 164 (6): 861-867. 10.1176/appi.ajp.164.6.861.

Abou-Saleh MT, Coppen A: The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J Psychiatr Res. 1986, 20 (2): 91-101. 10.1016/0022-3956(86)90009-9.

Abou-Saleh MT, Coppen A: Serum and red blood cell folate in depression. Acta Psychiatr Scand. 1989, 80 (1): 78-82. 10.1111/j.1600-0447.1989.tb01303.x.

Abou-Saleh MT, Coppen A: Folic acid and the treatment of depression. J Psychosom Res. 2006, 61 (3): 285-287. 10.1016/j.jpsychores.2006.07.007.

Gilbody S, Lewis S, Lightfoot T: Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007, 165 (1): 1-13. 10.1093/aje/kwj347.

McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, Gill M, Korszun A, Maier W, Middleton L, Mors O, Owen MJ, Perry J, Preisig M, Reich T, Rice J, Rietschel M, Jones L, Sham P, Farmer AE: Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet. 2005, 14 (22): 3337-3345. 10.1093/hmg/ddi363.

Demirhan O, Tastemir D: Cytogenetic effects of ethanol on chronic alcohol users. Alcohol Alcohol. 2008, 43 (2): 127-136.

Coppen A, Bailey J: Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord. 2000, 60 (2): 121-130. 10.1016/S0165-0327(00)00153-1.

Coppen A, Bolander-Gouaille C: Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005, 19 (1): 59-65. 10.1177/0269881105048899.

Coppen A, Chaudhry S, Swade C: Folic acid enhances lithium prophylaxis. J Affect Disord. 1986, 10 (1): 9-13. 10.1016/0165-0327(86)90043-1.

Black JL, O'Kane DJ, Mrazek DA: The impact of CYP allelic variation on antidepressant metabolism: a review. Expert Opin Drug Metab Toxicol. 2007, 3 (1): 21-31. 10.1517/17425255.3.1.21.

Camilleri M: Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterol Motil. 2007, 19 Suppl 2: 40-45. 10.1111/j.1365-2982.2007.00961.x.

McAlpine DE, O'Kane DJ, Black JL, Mrazek DA: Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clin Proc. 2007, 82 (9): 1065-1068.

Pestka EL, Hale AM, Johnson BL, Lee JL, Poppe KA: Cytochrome P450 testing for better psychiatric care. J Psychosoc Nurs Ment Health Serv. 2007, 45 (10): 15-18.